Inhibikase Therapeutics, Inc.

NasdaqCM:IKT Stock Report

Market Cap: US$13.8m

Inhibikase Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of IKT?
Owner TypeNumber of SharesOwnership Percentage
Private Companies13,2760.215%
Institutions486,4187.86%
Individual Insiders889,88714.4%
General Public4,796,69977.5%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 32.4%.


Top Shareholders

Top 18 shareholders own 22.46% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14.4%
Milton Werner
889,229US$2.0m0%no data
3.61%
FiveT Capital AG
223,500US$498.4k0%100.0%
1.33%
The Vanguard Group, Inc.
82,045US$183.0k-6.18%no data
0.97%
William Blair Investment Management, LLC
60,268US$134.4k1.5%no data
0.46%
Geode Capital Management, LLC
28,692US$64.0k0%no data
0.46%
Next Edge Capital Corp.
28,333US$63.2k0%0.24%
0.39%
Renaissance Technologies LLC
24,422US$54.5k51.5%no data
0.32%
Redmond Asset Management, LLC
19,644US$43.8k-6.35%0.01%
0.16%
State Street Global Advisors, Inc.
10,084US$22.5k0%no data
0.12%
Flagship Consulting Inc
7,357US$16.4k0%no data
0.096%
Tower Research Capital LLC
5,919US$13.2k169%no data
0.089%
Timber Point Capital Management LLC
5,500US$12.3k0%0.08%
0.032%
Royal Bank of Canada, Banking & Securities Investments
2,000US$4.5k0%no data
0.027%
Morgan Stanley, Investment Banking and Brokerage Investments
1,667US$3.7k0%no data
0.011%
Joseph Frattaroli
658US$1.5k0%no data
0.0027%
Wells Fargo & Company, Securities and Brokerage Investments
167US$372.5-16.5%no data
0.001%
Bank of America Corporation, Asset Management Arm
62US$138.00%no data
0.00055%
Wells Fargo & Company, Private Banking and Investment Banking Arm
34US$75.96.25%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.